Dr Walker

Founding Editor: Dr Richard F Walker

Dr Richard F Walker has broad experience in the theoretical and practical aspects of aging research derived from key positions in academia, industry. His education includes a BS in pharmacy (Rutgers University), an MS in biochemistry (New Mexico State University) and a PhD in endocrine physiology (Rutgers University). Postdoctoral training in Neuroendocrinology and Neuropharmacology of Aging was received at the Center for the Study of Aging and Human Development, Duke University Medical Center and at the University of California, Berkeley. Dr Walker has held academic positions in Clemson University, Sanders-Brown Research Center on Aging at the University of Kentucky Medical Center, Medical College of Pennsylvania and the University of South Florida College of Medicine. Consistent with a productive record of research as evidenced by extensive peer-reviewed publications, many federal, state, local grants including those from the NIH (NIA), NSF and DoD, as well as accomplishments in teaching and service, he was twice awarded tenure. Dr Walker also held administrative positions at his last institution that included Director of Research Compliance and Director of the Clinical Alliance for Research, Education and Service. While in the pharmaceutical industry, he held a director level position in research and development at SmithKline Beecham, Inc and he currently consultants for a number of companies through his own corporation. Dr Walker successfully prepared several investigational new drug applications (IND’s) to the FDA for studying hormone replacement in aging subjects, and with his colleague Dr Barry Bercu, has organized and co-chaired many international symposia on clinical interventions in aging. Consistent with his goal to promote evidence-based approaches to healthy aging, Dr Walker is coordinating development of the Society for Applied Research in Aging (SARA), which is devoted to that purpose. SARA’s official journal will be Clinical Interventions in Aging. Under his direction as founding editor it will provide a ethical forum for presentation of data and debate on issues relevant to medical practice that is less concerned with treating intrinsic diseases of aging than with sustaining health and vitality throughout life.

Dr Angehrn

Associate editor (Europe): Fiorenzo Angehrn

Fiorenzo Angehrn received his medical degree from the University of Zurich, Switzerland. Subsequently, he received postgraduate training in General Surgery in hospitals at Zurich, Glarus, and Biel-Bienne. His subspecialty training was taken at several outstanding Departments of Vascular Surgery including those at the University of Ulm, Germany, University of Bern, Switzerland, and Baylor University in Dallas, Texas, USA. His scientific interests focus on the clinical values of diagnostic methods including blood tests, scintigraphy, and sonography. Throughout his career, Dr Angehrn has been interested in developing interventions to maintain health and vitality across the life span. Evidence of this interest can be found in some of his works such as his book entitled Venenleiden Sind Vermeidbar (Venous Disorders Can be Avoided). To promote this interest among his colleagues he founded and currently presides over the Schweizerische Gesellschaft fur Medizinisches Anti-Aging (Swiss Society for Anti-Aging Medicine). In recognition of his work, Dr Angehrn has been an invited speaker at many prestigious anti-aging meetings and has received significant support from public and private sources for his efforts to promote the ethical and professional advancement of longevity medicine.

Dr Tsubota

Associate editor (Asia) Kazuo Tsubota

Internationally recognized dry eye specialist Professor Kazuo Tsubota has been working on the pathogenesis and treatment of dry eye. Professor Tsubota is Chairman of the Department of Ophthalmology at Keio University School of Medicine, his alma mater. He heads a very large and active dry eye research group as well as the largest refractive group in Japan. Dr. Tsubota has many research projects underway in the field of ophthalmology as well as anti-aging medicine in relation to ophthalmology. His basic research in the field of anti-aging medicine in ophthalmology focuses on the mechanism of age-related macular degeneration, which is one of the leading causes of blindness in western countries, and the second most common cause in Japan. Prof. Tsubota is the Editor-in-Chief of Anti-Aging Medicine, the journal of the Japanese Anti-Aging Society. http://www.tsubota.ne.jp